8-K/AShareholder Matters

CVS HEALTH Corp 8-K/A Report, Shareholder Vote Results (May 14, 2013)

Filed May 14, 2013For Securities:CVS

Summary

This 8-K filing from CVS Health (CVS) details the voting results from its Annual Meeting of Stockholders held on May 9, 2013. The report confirms overwhelming support for management's proposals, including the election of all nine director nominees and the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2013. Additionally, shareholders approved the company's executive compensation (on a non-binding basis), an amendment to the Employee Stock Purchase Plan to add shares, and a change to the voting thresholds for the 'fair price provision' in the company's certificate of incorporation. Conversely, three shareholder proposals were rejected. These proposals focused on political contributions, accelerated equity award vesting upon a change in control, and lobbying reports. The significant majority of votes cast in favor of management-backed items and against shareholder-driven initiatives suggest a strong alignment between the company's strategy and its investor base at that time.

Key Highlights

  • 1All 9 director nominees were overwhelmingly elected for one-year terms.
  • 2Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2013 with strong shareholder approval.
  • 3Shareholders approved, on a non-binding basis, the compensation of named executive officers.
  • 4An amendment to the 2007 Employee Stock Purchase Plan to add shares was approved by a significant majority.
  • 5A proposed amendment to the Certificate of Incorporation to adjust voting thresholds for the 'fair price provision' was also approved.
  • 6Three shareholder proposals requesting reports on political contributions, accelerated executive equity vesting upon change of control, and lobbying were all rejected.

Frequently Asked Questions

The meeting resulted in the re-election of all director nominees, ratification of the independent auditor (Ernst & Young LLP), approval of executive compensation (non-binding), amendments to the Employee Stock Purchase Plan and the Certificate of Incorporation. Importantly, three shareholder proposals concerning political contributions, change-in-control equity vesting, and lobbying were rejected.

The compensation of CVS Health's named executive officers was put to a non-binding shareholder vote. The proposal was approved by a significant majority of the votes cast, indicating general shareholder satisfaction with the company's executive pay practices at that time.

No, all three shareholder proposals submitted for a vote at the May 9, 2013 Annual Meeting were rejected. These proposals related to political contributions, accelerated vesting of equity awards upon a change in control, and lobbying reports.

The approved amendment altered the voting thresholds required under the 'fair price provision' within CVS Health's Certificate of Incorporation. While the specific details of the previous and new thresholds are in the proxy statement, this type of amendment typically relates to the requirements for approving certain business combinations or takeovers, potentially impacting future corporate control transactions.